Global mRNA Therapeutics Market Analysis, 2024–2034

The Global mRNA Therapeutics Market Analysis Executive Summary

mRNA therapeutics use messenger RNA to make the body produce a protein, for vaccines, cancer treatments and rare diseases.

Key segments of the mRNA Therapeutics market include application (Infectious Disease Vaccines, Cancer Vaccines and Protein Replacement) and type (Prophylactic and Therapeutic).

Global mRNA Therapeutics Market Dynamics

Market Growth Drivers

Approvals of the first curative gene and cell therapies, strong investment in biotech, better manufacturing and growing evidence in rare and blood diseases are driving the mRNA Therapeutics market.

Opportunity

Allogeneic (off-the-shelf) products, in-vivo delivery and use in common diseases open large growth for the mRNA Therapeutics market.

Market Restraints

Very high prices, complex manufacturing, limited treatment centres and uncertain long-term safety hold back the mRNA Therapeutics market. Payers are still working out how to pay for one-time cures.

Competitive Landscape for mRNA Therapeutics Market in Global

The mRNA Therapeutics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

• MModerna
• BBioNTech
• Pfizer
• CCureVac
• AArcturus Therapeutics
• Sanofi

Healthcare Policies and Regulatory Landscape for mRNA Therapeutics Market in Global

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for mRNA Therapeutics. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Global.

1. 1 Market Analysis

   • 1.1 Research Scope and Assumption
   • 1.2 Objective of the study
   • 1.3 Research Methodology
   • 1.4 Reason to buy the report

2. 2 Market Analysis Executive Summary

   • 2.1 Market Analysis - Industry Snapshot & key buying criteria, 2025-2034
   • 2.2 Market Size, Growth Prospects and Key findings

3. 3 Market Dynamics

   • 3.1 Market Growth Drivers Analysis
   • 3.2 Market Restraints Analysis

4. 4 Market Segmentation

   • 4.1 By Application
   • 4.2 By Type
   • 4.3 By End User

5. 5 By Market Share

   • 5.1 Market Analysis, Insights and Forecast – By Revenue

6. 6 Competitive Landscape

   • 6.1 Major Top Market Players Products in Pipeline
   • 6.2 R&D Initiatives
   • 6.3 Notable recent Deals
   • 6.3.1 Strategic Divestments
   • 6.3.2 Mergers & Acquisitions
   • 6.3.3 Partnerships
   • 6.3.4 Joint Ventures

7. 7 Key Company Profiles

   • 7.1 Moderna
   • 7.2 BioNTech
   • 7.3 Pfizer
   • 7.4 CureVac
   • 7.5 Arcturus Therapeutics
   • 7.6 Sanofi

8. 8 Healthcare Policies and Regulatory Landscape

   • 8.1 Policy changes and Reimbursement scenario
   • 8.2 Government Initiatives / Intervention programs

The mRNA Therapeutics market can be segmented based on various criteria, including application, type and end user. Here's a breakdown of the market segmentation